These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16541500)

  • 21. Project Inform analysis: results of a "cure" study.
    Proj Inf Perspect; 2006 Jan; (40):5-7. PubMed ID: 16718904
    [No Abstract]   [Full Text] [Related]  

  • 22. 25 years of HIV.
    Fauci AS
    Nature; 2008 May; 453(7193):289-90. PubMed ID: 18480799
    [No Abstract]   [Full Text] [Related]  

  • 23. Infectious disease. HIV prevention and cure insights come from failure and success.
    Cohen J
    Science; 2012 Mar; 335(6074):1291. PubMed ID: 22422953
    [No Abstract]   [Full Text] [Related]  

  • 24. Establishment of drug-resistant HIV-1 in latent reservoirs.
    Dahl V; Palmer S
    J Infect Dis; 2009 May; 199(9):1258-60. PubMed ID: 19338473
    [No Abstract]   [Full Text] [Related]  

  • 25. The epidemiology of HIV coreceptor tropism.
    Hoffmann C
    Eur J Med Res; 2007 Oct; 12(9):385-90. PubMed ID: 17933718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing HIV. Understanding the pharmacodynamics.
    Miller SK
    Adv Nurse Pract; 2000 May; 8(5):58-60, 65-6. PubMed ID: 11235335
    [No Abstract]   [Full Text] [Related]  

  • 27. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.
    Kouanfack C; Montavon C; Laurent C; Aghokeng A; Kenfack A; Bourgeois A; Koulla-Shiro S; Mpoudi-Ngole E; Peeters M; Delaporte E
    Clin Infect Dis; 2009 May; 48(9):1318-22. PubMed ID: 19320592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
    Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
    J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antivirals: Winning at hide-and-seek with latent HIV reservoirs.
    Cully M
    Nat Rev Drug Discov; 2016 Aug; 15(8):532. PubMed ID: 27444221
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment interruptions in HIV-infected subjects.
    Bongiovanni M; Casana M; Tincati C; d'Arminio Monforte A
    J Antimicrob Chemother; 2006 Sep; 58(3):502-5. PubMed ID: 16816398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corruption and HIV/AIDS. Accountability in a time of crisis.
    Kasper T
    IAPAC Mon; 2006 Feb; 12(2):40. PubMed ID: 17249136
    [No Abstract]   [Full Text] [Related]  

  • 32. StpC-based gene therapy targeting latent reservoirs of HIV-1.
    Turner LS; Tsygankov AY; Henderson EE
    Antiviral Res; 2006 Dec; 72(3):233-41. PubMed ID: 16891001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of early initiation of protease inhibitor-sparing antiretroviral regimen in human immunodeficiency virus-1 vertically infected infants.
    Van der Linden D; Hainaut M; Goetghebuer T; Haelterman E; Schmitz V; Maes P; Peltier A; Levy J
    Pediatr Infect Dis J; 2007 Apr; 26(4):359-61. PubMed ID: 17414406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Better results from vicriviroc with new Trofile test.
    Proj Inf Perspect; 2008 Dec; (47):12. PubMed ID: 19227563
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
    Wilson LE; Gallant JE
    Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New developments in HIV drug resistance.
    Cane PA
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i37-40. PubMed ID: 19675018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global treatment update.
    Gonsalves G
    GMHC Treat Issues; 2002 Nov; 16(11):15. PubMed ID: 12541990
    [No Abstract]   [Full Text] [Related]  

  • 39. Maturation inhibitors as new antiretroviral agents.
    Richards J; McCallister S
    J HIV Ther; 2008 Dec; 13(4):79-82. PubMed ID: 19418657
    [No Abstract]   [Full Text] [Related]  

  • 40. Part XV. Antiretroviral therapy for human immunodeficiency virus infection.
    Stephens JR; Rathbun RC; Lockhart SM; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Nov; 100(11):417-24. PubMed ID: 18183858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.